medigraphic.com
ISSN 2395-8723 (Electronic)
ISSN 1405-888X (Print)
TIP Revista Especializada en Ciencias Químico-Biológicas

2021, Number 1

<< Back Next >>

TIP Rev Esp Cienc Quim Biol 2021; 24 (1)

Chrysobalanus icaco L.: source of phytochemicals with bioactive potential against metabolic syndrome in México

Jiménez-Ortega LA, Gutiérrez-Grijalva EP, Contreras-Angulo LA, Basilio HJ

Language: English
References: 88
Page:
PDF size: 362.63 Kb.


ABSTRACT

The change in the Mexican population’s lifestyle and diet has led to a significant development of chronic degenerative diseases, such as diabetes, obesity, hypertension, and metabolic syndrome (MetS), which generate a serious public health problem. Moreover, considering recent evidence, these comorbidities are also pivotal factors in the progression and prognosis of respiratory diseases. The development of new treatments and the search for compounds from profitable sources such as plants can mitigate the problem. Chrysobalanus icaco is a plant used around the world, highlighting it’s medicinal and food uses. Different secondary metabolites have been isolated and identified from fruits, leaves, roots, seeds, and stems of C. icaco. Most studies have focused on phenolic compounds, terpenoids, and alkaloids, as well as their functional properties. This review aimed to describe the phytochemical content and hypoglycemic, antiobesogenic, and anti-inflammatory potential of C. icaco, a fruit consumed for medicinal and nutritional purposes in southern Mexico.


REFERENCES

  1. Aceves-Martins, M., López-Cruz, L., García-Botello, M., Gutiérrez-Gómez, Y. Y. & Moreno-García, C. F. (2021). Interventions to Treat Obesity in Mexican Children and Adolescents: Systematic Review and Meta- Analysis, Nutrition Reviews, nuab041, DOI: 10.1093/ nutrit/nuab041.

  2. Alves, F. E., Satiro, X. H. & Perreli, R. K. (2012). Chrysobalanaceae: traditional uses, phytochemistry and pharmacology. Revista Brasileira de Farmacognosia, 25(5), 1181-1186. DOI:10.1590/S0102-695X2012005000080.

  3. Andrade-Cetto, A. & Heinrich, M. (2005). Mexican plants with hypoglycaemic effect used in the treatment of diabetes. Journal of Ethnopharmacology, 99, 325-348. DOI: 10.1016/j.jep.2005.04.019.

  4. Andrade-Cetto, A., Carola, C. E., Cabello-Hernández, C. A. & Cárdenas-Vázquez, R. (2019). Hypoglycemic Activity of Medicinal Plants Used among the Cakchiquels in Guatemala for the Treatment of Type 2 Diabetes. Evidence-Based Complementary and Alternative Medicine. 2019, 1-7. DOI: 10.1155/2019/2168603.

  5. Araújo-Filho, H. G., Dias, J. D. S., Quintans-Júnior, L. J., Santos, M. R. V., White, P. A. S., Barreto, R. S. S., Barreto, A. S., Estevam, C. S., Araujo, S. S., Almeida, J. G. S., Menezes, I. R. A., Coutinho, H. D. M. & Quintans, J. S. S. (2016). Phytochemical screening and analgesic profile of the lyophilized aqueous extract obtained from Chrysobalanus icaco leaves in experimental protocols. Pharmaceutical Biology, 54(12), 3055-3062. DOI:10.1080/13880209.20 16.1204618.

  6. Barbosa, W. L. R., Peres, A., Gallori, S. & Vincieri, F. F. (2006). Determination of myricetin derivatives in Chrysobalanus icaco L. (Chrysobalanaceae). Revista Brasileira de Farmacognosia, 16(3), 333-337.

  7. Bastos, S. J. P., Noronha, P. A. R. M., Portal, P. T., Brígida, S. A. S., Baetas, A. C., Ramos, B. W. L., Chagas, M. M & Ataíde, A. M. (2017). Antifungal Activity of Hydroalcoholic Extract of Chrysobalanus icaco Against Oral Clinical Isolates of Candida Species. Pharmacognosy Research, 9(1), 96-100. DOI:10.4103/0974-8490.199772.

  8. Betancourt-Núñez, A., Márquez-Sandoval, F., Babio, N. & Vizmanos, B. (2018). Metabolic syndrome components in young health professionals; LATIN America METabolic Syndrome (LATINMETS) México study. Nutrición Hospitalaria, 35(4), 864-873. DOI: 10.20960/nh.1694.

  9. Bezerra, O. T., Reis, C. J. C. H., Barreto, M. F.V., Correa, A. L. C., Sousa, M. M. B., Perrelli, R. K., Carneiro, N. S. & Goncalves, S. T. (2014). Anti-inflammatory and Antinociceptive Effects of the Aqueous Extract of the Bark of Chrysobalanus icaco Linnaeus. British Journal of Pharmaceutical Research, 4(19), 1253-1268.

  10. Brown, S. H. & Frank, M. S. (2018). Cocoplum (Chrysobalanus icaco L.) Identification and Uses. University of Florida, IFAS Extension, ENH1289. 1-9. https://edis.ifas.ufl.edu/ pdffiles/EP/EP55300.pdf.

  11. Canto-Osorio, F., Denova-Gutiérrez, E., Sánchez-Romero, L. M., Salmeron, J. & Barrientos-Gutoerrez. (2020). Dietary Inflammatory Index and metabolic syndrome in Mexican adult population. The American Journal of Clinical Nutrition, 112(2), 373-380. DOI: 10.1093/ajcn/nqaa135.

  12. Carnevale, N. F., Pilon, A. C., Da Silva B. V. & Castro-Gamboa, I. (2013). Chrysobalanaceae: secondary metabolites, ethnopharmacology and pharmacological potential. Phytochemistry Reviews, 12(1), 121-146. DOI:10.1007/ s11101-012-9259-z.

  13. Castilho, R. O. & Kaplan, M. A. C. (2011). Phytochemical study and antimicrobial activity of Chrysobalanus icaco. Chemistry of Natural Compounds, 47(3), 436-437. DOI:10.1007/s10600-011-9953-x.

  14. Castro, J. C. J., Villa, R. N., Ramírez, G. A. & Mosso, G. C. (2014). Uso medicinal de plantas antidiabéticas en el legado etnobotánico oaxaqueño. Revista Cubana de Plantas Medicinales, 19(1), 101-120.

  15. Chukwuma, C. I., Mashele, S. S. & Amaka, A. E. (2020). Evaluation of the in vitro ⍺-amylase inhibitory, antiglycation, and antioxidant properties of Punica granatum L. (pomegranate) fruit peel acetone extract and its effect on glucose uptake and oxidative stress in hepatocytes. Journal of Food Biochemistry, 4, e13175. DOI: 10.1111/jfbc.13175.

  16. Coelho-Ferreira, M. (2009). Medicinal knowledge and plant utilization in an Amazonian coastal community of Marudá, Pará State (Brazil). Journal of Ethnopharmacology, 126(1), 159-175. DOI: 10.1016/j.jep.2009.07.016.

  17. Costa, F. F., Rosário, W. R., Farías, R. A. C., de Souza, G. R., Duarte, G. R. S. & Barroso, A. W. (2020). Metabolic syndrome and COVID-19: An update on the associated comorbidities and proposed therapies. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 14, 809-814. DOI: 10.1016/j.dsx.2020.06.016.

  18. Da Silva, P. P., Campos, C. R., Teixeira, G. H. & Prado, M. A. (2013). The phenolic compounds and the antioxidant potential of infusion of herbs from the Brazilian Amazonian region. Food Research International, 53(2), 875-881. DOI: 10.1016/j.foodres.2013.02.010.

  19. Davies, R. M. & Zibokere, D. S. (2011). Some Physical Properties of Gbafilo (Chrysobalanus icaco) Fruits and Kernels Preparatory to Primary Processing. International Journal of Agricultural Research, 6(12), 848-855. DOI: 10.3923/ijar.2011.848.855.

  20. De Albuquerque, U. P., Monteiro, J. M., Alves, R. M. & Cavalcanti, A. E. L. & de Amorim, E. L. C. (2007). Medicinal and magic plants from a public market in northeastern Brazil. Journal of Ethnopharmacology, 110(1), 76-91. DOI: 10.1016/j.jep.2006.09.010.

  21. De Brito, E. S., de Araújo, M. C. P., Alves, R. E., Carkeet, C., Clevidence, B. A. & Novotny, J. A. (2007). Anthocyanins Present in Selected Tropical Fruits: Acerola, Jambolão, Jussara, and Guajiru. Journal of Agricultural and Food Chemistry, 55(23), 9389-9394. DOI: 10.1021/jf0715020.

  22. De Oliveira, B. A. P., de Oliveira, S. G., Cortes, de M. I. A., Rezende, N. J. M., Bitencurt, J. L. C., dos Santos, E. C., Bion, de L. A. C., Thomazzi, S. M., Gibara, G. A., Quintans- Junior, L. J. & Viana, dos S. M. R. (2013). Antidiabetic Effect of the Chrysobalanus icaco L. Aqueous Extract in Rats. Journal of Medicinal Food, 16(6), 538-543. DOI: 10.1089/jmf.2012.0084.

  23. Escandón-Rivera, S. M., Mata, R. & Andrade-Cetto, A. (2020). Molecules Isolated from Mexican Hypoglycemic Plants: A Review. Molecules, 25(18), 4145. DOI: 10.3390/ molecules25184145.

  24. Espinosa, P. L. N. (2016). Tratamiento de la obesidad con productos naturales. Enfermería Investiga, Investigación, Vinculación, Docencia y Gestión, 1(4), 164-168.

  25. Espinosa-Osornio, G., Vargas-Simón, G. & Engleman, M. (2002). Contribución al estudio de la anatomía foliar del icaco (Chrysobalanus icaco L.). Bioagro, 14(1), 29-36.

  26. Fernandes, J., Oliveira, C. R., Rangel, C. M., Wagner-Souza, K., Coelho, K. M. A. & Rocha, G. C. (2003). Pentacyclic triterpenes from Chrysobalanaceae species: cytotoxicity on multidrug-resistant and sensitive leukemia cell lines. Cancer Letters, 190(2), 165-169. DOI: 10.1016/S0304- 3835(02)00593-1.

  27. Fernandes, J., Weinlich, R., Oliveira, C. R., Amarante-Mendes, G. P. & Rocha, G. C. (2007). Pomolic acid may overcome multidrug resistance mediated by overexpression of antiapoptotic Bcl-2 proteins. Cancer Letters, 245, 315-320. DOI: 10.1016/j.canlet.2006.01.009.

  28. Fernández-Travieso, J. C. (2016). Síndrome Metabólico y Riesgo Cardiovascular. Revista CENIC Ciencias Biológicas, 47(2), 106-199.

  29. Ferreira-Machado, S. C., Gagliardi, R. F., Nunes, A. P. M., Rodrigues, M. P., Dantas, F. J. S., De Mattos, J. C. P., Peregrino, C. A. F., Moura, E. G. & Caldeira-de-Araujo. (2014). Antidiabetic and genotoxic effects on Wistar rats treated with aqueous extract from Chrysobalanus icaco L. Journal of Medicinal Plants Research, 8(1), 52-57. DOI: 10.5897/JMPR2013.5312.

  30. Flores, R. J., Rivera, F. M. M., Apodaca, C. A., Saldaña, M. M. C., Urbalejo C. V. I., Meneses, G. A., Herrera, G. A., Sevilla, G. M. L. & Pérez, C. D. A. (2019). Incidence and characteristics of metabolic syndrome in patients of the National Cancer Institute of Mexico. Nutrición Hospitalaria, 36(6), 1296-1299. DOI: 10.20960/nh.02395.

  31. Fonseca-Kruel, V. S., Rodrigues, N. M. E., Dunn, A. D. S. & Prance, G. T. (2020). Ethnobotany of Bajiru (Chrysobalanus icaco L.) In a Coastal Vegetation of Southeastern Brazil. Research Square (Preprint), 1-15. DOI: 10.21203/ rs.2.21438/v1.

  32. García, R. M. J., Camarillo, A. J., Valenzuela, G. M. J., López, J. A. & Ramírez, S. S. (2021). ADIPQ gene polymorphism rs266729 (-11377 C > G) and metabolic syndrome risk in a Mexican population of western Mexico. Nutrición Hospitalaria, 38(1), 67-72. DOI: 10.20960/nh.03204

  33. Ginwala, R., Bhavsar, R., Chigbu, D. G. I., Jain, P. & Khan, Z. K. (2019). Potential Role of Flavonoids in Treating Chronic Inflammatory Diseases with a Special Focus on the Anti-Inflammatory Activity of Apigenin. Antioxidants, 8(35), 2-30. DOI: 10.3390/antiox8020035.

  34. Gunstone, F. D. & Subbarao, R. (1967). New tropical seed oils. Part I. conjugated trienoic and tetraenoic acids and their oxo derivatives in the seed oils of Chrysobalanus icaco and Parinarium laurinum. Chemistry and Physics of Lipids, 1, 349-359.

  35. Gustafson, K. R., Munro, M. H. G., Blunt, J. W., Cardellina, J. H., McMahon, J. B., Gulakowski, R. J., Cragg, G. M., Cox, P. A., Brinen, L. S., Clardy, J. & Boyd, M. R. (1991). HIV inhibitory natural products. 3. Diterpenes from Homalantus acuminatus and Chrysobalanus icaco. Tetrahedron, 47(26), 4547-4554. DOI: 10.1016/S0040- 4020(01)86461-9.

  36. Gutiérrez-Esparza, G. O., Infante Vázquez, O., Vallejo, M. & Hernández-Torruco, J. (2020). Prediction of Metabolic Syndrome in a Mexican Population Applying Machine Learning Algorithms. Symmetry, 12, 581. DOI: 10.3390/ sym12040581.

  37. Hernández, Z. G. A., Martínez-Moreno, E. & Castañón- Nájera, G. (2018). Usos actuales y potenciales del icaco (Chrysobalanus icaco L.) en Tabasco, México. Memoria del VI Congreso Internacional y XX Congreso Nacional de Ciencias Agronómicas, 24 al 27 de abril de 2018, Chapingo, Estado de México, México. 647-648.

  38. Heymsfield, S. B. & Wadden, T. A. (2017). Mechanisms, Pathophysiology, and Management of Obesity. The New England Journal of Medicine, 376, 254-266. DOI: 10.1056/ NEJMra1514009.

  39. Ibarra, M. J., Cantú, P. C., Verde, M. J. & Oranday, A. (2009). Caracterización Fitoquímica y Efecto Hipoglucemiante de Tecoma stans y su Relación con la Presencia del Cromo como Factor de Tolerancia a la Glucosa. Información Tecnológica, 20(5), 55-65. DOI: 10.1612/inf.tecnol.4121it.08.

  40. INEGI, Instituto Nacional de Estadística y Geografía (2020). Prevalencia de Obesidad, Hipertensión y Diabetes para los Municipios de México 2018. https://www.inegi.org.mx/ investigacion/pohd/2018/.

  41. INEGI, Instituto Nacional de Estadística y Geografía (2021). Comunicado de prensa Núm. 61/21. Características de las defunciones registradas en México durante enero a agosto de 2020.https://www.inegi.org.mx/ contenidos/saladeprensa/boletines/2021/EstSociodemo/ DefuncionesRegistradas2020_Pnles.pdf.

  42. INSP, Instituto Nacional de Salud Pública (2020). ¿De qué mueren los mexicanos? https://www.insp.mx/avisos/5111- dia-muertos-mexicanos.html.

  43. INSP e INEGI, Instituto Nacional de Salud Pública); Instituto Nacional de Estadística y Geografía (2018). Encuesta Nacional de Salud y Nutrición ENSANUT 2018. https:// ensanut.insp.mx/encuestas/ensanut2018/doctos/informes/ ensanut_2018_presentacion_resultados.pdf.

  44. IDF, International Diabetes Federation (2020). The IDF worldwide definition of the Metabolic syndrome. https://www.idf.org/e-library/consensus-statements/60- idfconsensus-worldwide-definitionof-the-metabolicsyndrome. html.

  45. Jamar, G., Boveto, S. A., Flygare, A. C., Gagliardi, A., Vera, R.V., Zuniga, D.V. & Pellegrini, P. L. (2020). Effects of the juçara fruit supplementation on metabolic parameters in individuals with obesity: a double-blind randomized controlled trial. The Journal of Nutritional Biochemistry, 83(108430), 1-8. DOI: 10.1016/j.jnutbio.2020.108430.

  46. Jiménez, G. M. E., Méndez, B. E. S., Lesher, G. J. M., Molina, M. R. F. & Hernández, M. R. (2011). Una ventana al estudio del genoma del Chrysobalanus icaco L. Kuxulkab, Revista de Divulgación, 17(33), 61-65.

  47. Katalinic, V., Milos, M., Kulisic, T. & Jukic. (2006). Screening of 70 medicinal plant extracts for antioxidant capacity and total phenols. Food Chemistry, 94, 550-557. DOI: 10.1016/j. foodchem.2004.12.004.

  48. Kim, S., Chen, J., Cheng, T., Gindulyte, A., He, J., He, S., Li, Q., Shoemaker, B. A., Thiessen, P. A., Yu, B., Zaslavsky, L., Zhang, J. & Bolton, E. E. (2019). New data content and improved web interfaces. Nucleic Acids Research, 49(D1), D1388–D1395. DOI: 10.1093/nar/gkaa971.

  49. Lanktree, M. B. & Hegele, R. A. (2018). Metabolic Syndrome. Genomic and Precision Medicine. Cardiovascular Disease. Edited by: Ginsburg, G. S. & Willard, G. F. Third Edition. 47-63 pp. DOI: 10.1016/B978-0-12-801812-5.00015-9.

  50. Lim, S. & Eckel. (2014). Pharmacological treatment and therapeutic perspectives of metabolic syndrome. Reviews in Endocrine and Metabolic Disorders, 15, 329-341. DOI: 10.1007/s11154-014-9298-4.

  51. Magaña, G. J. A., Moreno-Mascareño, D., Angulo, R. C. E. & de la Peña, G. D. (2020). Association of Total and High Molecular Weight Adiponectin with Components of Metabolic Syndrome in Mexican Children. The Journal of Clinical Research in Pediatric Endocrinology, 12(2), 180-188. DOI: 10.4274/jcrpe.galenos.2019.2019.0113.

  52. May, M., Schindler, C. & Engeli, E. (2020). Modern pharmacological treatment of obese patients. Therapeutic Advances in Endocrinology and Metabolism, 11, 1-19. DOI. 10.1177/2042018819897527.

  53. Medeiros, A. T., Luo, R., Almeida, M. A., Azevedo-Meleiro, C. H., Sabaa-Srur, A. U., Tran, K. & Smith, R. E. (2017). Chemical Characterization of Cocoplum (Chrysobalanus icaco, L) Seed Oil and Seeds. Journal of Regulatory Sciences, 5(2), 15-28. 53. Mendoza-Caamal, E. C., Barajas-Olmos, F., Garcia-Ortiz, H., Cicerón-Arellano, I., Martínez-Hernández, A., Córdova, E. J., Esparza-Aguilar, M., Contreras-Cubas, C., Centeno- Cruz, F., Cid-Soto, M., Morales-Marín, M. E., Reséndiz- Rodríguez, A., Jiménez-Ruíz J. L., Salas-Martínez, M. G., Saldaña-Alvarez, Y., Mirzaeicheshmeh, E., Rojas- Martínez, M. R. & Orozco, L. (2020). Metabolic syndrome in indigenous communities in México: a descriptive and cross-sectional study. BMC Public Health, 20, 339. DOI: 10.1186/s12889-020-8378-5.

  54. Mopuri, R., Ganjayi, M., Meriga, B., Koorbanally, N. A. & Islam, S. M. (2018). The effects of Ficus carica on the activity of enzymes related to metabolic syndrome. Journal of Food and Drug Analysis, 26, 201-210. DOI: /10.1016/j. jfda.2017.03.001.

  55. Nayak, B. S., Marshall, R. J., Milne, D., Kanhai, K., Kantikar, S. M. & Raju, S. S. (2011). Hypoglycaemic Activity of Chrysobalanus icaco (Fat-pork) Fruit Extract in Diabetes Induced Rats. Asian Journal of Pharmaceutical and Biological Research, 1(4), 512-217.

  56. Neveu, V., Perez-Jiménez, J., Vos, F., Crespy, V., du Chaffaut, L., Mennen, L., Knox, C., Eisner, R., Cruz, J., Wishart, D. & Scalbert, A. (2010). Phenol-Explorer: a comprehensive online database on polyphenol contents in foods. Database, Bap024. DOI: 10.1093/database/bap024.

  57. NIH, National Heart, Lung, and Blood Institute (2020). Metabolic Syndrome. https://www.nhlbi.nih.gov/healthtopics/ metabolic-syndrome.

  58. Ortiz-Rodríguez, M. A., Aldaz-Rodríguez, M. V., González- Robledo, L. M., Villa, A., Bouzas, C., Pastor, R. & Tur, J. A. (2021). Association between the Use of Health Services, Cardiovascular Risk Factors and Metabolic Syndrome in Mexican Adults. International Journal of Environmental Research and Public Health, 18(5336), 1-11. DOI: 10.3390/ ijerph18105336.

  59. Ota, A. & Ulrih, N. P. (2017). An Overview of Herbal Products and Secondary Metabolites Used for Management of Type Two Diabetes. Frontiers in Pharmacology, 8, 436. DOI: 10.3389/fphar.2017.00436.

  60. Pacheco, L. S., Hernández-Ontiveros, D. A., Iñiguez-Stevens, E. Brodine, S., Garfein, R. S., Santibañez, M. & Fraga, M. A. (2018). Prevalence and correlates of diabetes and metabolic syndrome in a rural indigenous community in Baja California, México. BMC Public Health, 18, 1397 DOI: 10.1186/s12889-018-6276-x.

  61. Paracampo, N. E. N. P., Prance, G. T., Poppi, R. J. & Da Silva, J. A. F. (2017). Chemotaxonomic study of Chrysobalanus icaco Linnaeus (Chrysobalanaceae) using ultra-high performance liquid chromatography coupled with diode array detection fingerprint in combination with multivariate analysis. Journal of Separation Science, 40(10), 2161-2169. DOI: 10.1002/jssc.201770102.

  62. Payab, M., Hasani-Ranjbar, S., Shahbal, N., Qorbani, M., Aletaha, A., Haghi-Aminjan, H., Soltani, A., Khatami, F., Nikfar, S., Hassani, S., Abdollahi, M. & Larijani, B. (2019). Effect of the herbal medicines in obesity and metabolic syndrome: A systematic review and meta‐analysis of clinical trials. Phytoterapy Research, 34, 526-545. DOI: 10.1002/ptr.6547.

  63. Pérez-Rodríguez, M. P., Talavera, J. O. & Salmerón, J. (2021). Diet Quality, Physical Activity, and Weight Changes and Their Association With 6-Year Risk of Metabolic Syndrome in Mexican Adults. American Journal of lifestyle Medicine. DOI: 10.1177/15598276211017488.

  64. Portela-de-Sá, H. H., de Freitas, P. A., de Oliveira, K. A., Gomes, V. Y. A., Prado, V. R., da Cruz, F. S. G., Chaves, S. E., Bezerra, P. E. O., Costa, M. C. S., Coelho-de-Souza, A. N., Leal-Cardoso, J. H., Catunda, B. L. & Cunha, O. A. (2020). Effect of an aqueous extract of Chrysobalanus icaco on the adiposity of Wistar rats fed a high-fat diet. Nutrición Hospitalaria, 37(4), 763-769.

  65. Prance, G. T. (1972). Chrysobalanaceae, Flora Neotropica Monograph (Vol. 9). New York, USA: Hafner Publishing Company, Inc.

  66. Prance, G. T. (1989). Flora neotropical 9S Chrysobalanaceae. New York, USA: The New York Botanical Garden, 267 p.

  67. Prance, G. T. & Sothers, C. S. (2003). Species Plantarum, Flora of the World, Chrysobalanaceae 1. Canberra, Australia: Australian Biological Resources Study, 166 p.

  68. Ramírez, G., Zavala, M., Pérez, J. & Zamilpa, A. (2012). In vitro Screening of Medicinal Plants Used in Mexico as Antidiabetics with Glucosidase and Lipase Inhibitory Activities. Evidence-Based Complementary and Alternative Medicine, 2012, 701261. DOI: 10.1155/2012/701261.

  69. Ribeiro, N. E., Pereira, P. S., Bezerra, O. T., de Arruda, L. S. M., Sarmento, S.T. M., Delmiro, S. A. L. B., Silva, N. M., Moreno, S. R., Coelho, T. A. A. & Goncalves, S. T. (2020). Acute and repeated dose 28-day oral toxicity of Chrysobalanus icaco L. leaf aqueous extract. Regulatory Toxicology and Pharmacology, 113, 104643. DOI: 10.1016/j.yrtph.2020.104643.

  70. Romero-Velarde, E., Aguirre-Salas, L. M., Álvarez-Román, Y. A., Vásquez-Garibay, E. M., Fonseca-Reyes, S. (2015). Prevalencia de síndrome metabólico y factores asociados en niños y adolescentes con obesidad. Revista Médica del Instituto Mexicano del Seguro Social, 54(5), 568-575.

  71. Saeedi, P., Petersohn, I., Salpea, P., Malanda, B., Karuranga, S., Unwin, N., Colagiuri, S., Guariguata, L., Motala, A. A., Ogurtsova, K., Shaw, J. E., Brighy, D. & Williams, R. (2019). Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Research and Clinical Practice, 157, 107843. DOI: 10.1016/j.diabres.2019.107843.

  72. Sakulnarmrat, K. & Konczak, I. (2012). Composition of native Australian herbs polyphenolic-rich fractions and in vitro inhibitory activities against key enzymes relevant to metabolic syndrome. Food Chemistry, 134, 1011-1019. DOI: 10.1016/j.foodchem.2012.02.217.

  73. Salazar-Gómez, A., Ontiveros-Rodríguez, J. C., Pablo-Pérez, S. S., Vargas-Díaz, M. E. & Garduño-Siciliano, L. (2020). The potential role of sesquiterpene lactones isolated from medicinal plants in the treatment of the metabolic syndrome - A review. South African Journal of Botany, 135, 240-251. DOI: 10.1016/j.sajb.2020.08.020.

  74. Serván, P. R. Obesity and Diabetes. (2013). Nutrición Hospitalaria, 28(Supl.5), 138-143.

  75. Silva, B. J. P., Peres, N. A. R. M., Paixão, P. T., Silva, B. A. S., Baetas, A. C., Barbosa, R. W. L., Monteiro, C. M. & Andrade, M. A. (2017). Antifungal Activity of Hydroalcoholic Extract of Chrysobalanus icaco Against Oral Clinical Isolates of Candida Species. Pharmacognosy Research, 9, 96-100. DOI: 10.4103/0974-8490.199772.

  76. Skerget, M., Kotnik P., Hadolin, M., Rizner, H. A., Simonic, A. & Knez, Z. (2005). Phenols, proanthocyanidins, flavones and flavonols in some plant mayerials and their antioxidant activities. Food Chemistry, 89, 191-198. DOI: 10.1016/j. foodchem.2004.02.025.

  77. Vargas, C. E., Mendes, M. F., Azevedo, D. A., Pessoa, F. L. P. & Uller, A. C. (2010). Extraction of the essential oil of abajeru (Chrysobalanus icaco) using supercritical CO2. The Journal of Supercritical Fluids, 54(2), 171-177. DOI: 10.1016/j.supflu.2009.12.007.

  78. Vargas-Simón, G., Soto-Hernández, R.M. & Rodríguez- González, M.T. (2002). Análisis preliminar de antocianinas en fruto de icaco (Chrysobalanus icaco L.). Revista Fitotecnia Mexicana, 25(3), 261-264.

  79. Vargas-Simón, G., Soto-Hernández, R. M., Rodríguez-González, M. T. & Escalante-Estrada, J. A. (2000). Análisis fitoquímico preliminar del fruto de icaco (Chrysobalanus icaco L.): flavonoles y flavonas. Revista Chapingo Serie Horticultura, 6(2), 195-198.

  80. Venancio, V. P., Almeida, M. R. & Antunes, L. M. G. (2018). Cocoplum (Chrysobalanus icaco L.) decreases doxorubicininduced DNA damage and downregulates Gadd45a, Il-1β, and Tnf-α in vivo. Food Research International, 105, 996- 1002. DOI: 10.1016/j.foodres.2017.12.009.

  81. Venancio, V. P., Camargo, M. M., Ribeiro, A. M., Barros, M. L. R., de Oliveira, S.V. C., Barbosa, J. F., Pires, B. M. L., Marzocchi-Machado, C. M., Zerlotti, M. A. & Greggi, A. L. M. (2016). Chrysobalanus icaco L. fruits inhibit NADPH oxidase complex and protect DNA against doxorubicininduced damage in Wistar male rats. Journal of Toxicology and Environmental Health, Part A, 79(20), 885-893. DOI: 10.1080/15287394.2016.1193454.

  82. Venancio, V. P., Cipriano, P. A., Kim, H., Antunes, L. M. G., Talcott, S. T. & Mertens-Talcott, S. U. (2017). Cocoplum (Chrysobalanus icaco L.) anthocyanins exert antiinflammatory activity in human colon cancer and nonmalignant colon cells. Food & Function, 8(1), 307-314. DOI:10.1039/C6FO01498D.

  83. Villagra, E., Quintero, E., Mero, A., Guerrero, L. E., Morán- Pinzón, J. A., Palermo, J. A. & Patiño, C. L. P. (2020). Caracterización química y actividad biológica de las hojas y semillas de Chrysobalanus icaco L. (Icaco). Revista Cubana de Plantas Medicinales, 25(1), e903.

  84. Villareal-Ibarra, E. C., Lagunes-Espinoza, L. C., López, P. A., García-López, E., Palma-López, D. J., Ortiz- García, C. F. & Oranday-Cárdenas, M. A. (2015). Evaluación etnofarmacológica de plantas con propiedades hipoglucémicas usadas en la medicina tradicional del sureste de México. Boletín Latinoamericano y del Caribe de Plantas Medicinales y Aromáticas, 14 (2), 99-112. 84. Wagh, A. & Stone, N. J. (2004). Treatment of metabolic syndrome. Expert Review of Cardiovascular Therapy,2(2), 213–228. DOI:10.1586/14779072.2.2.213.

  85. White, P. A. S., Araújo, J. M. D., Cercato, L. M., Souza, L. A., Barbosa, A. P.O., Quintans-Junior, L. J., Machado, U. F., Camargo, E. A., Brito, L. C. & Santos, M. R. V. (2016b). Chrysobalanus icaco L. Leaves Normalizes Insulin Sensitivity and Blood Glucose and Inhibits Weight Gain in High-Fat Diet-Induced Obese Mice. Journal of Medicinal Food, 19(2), 155-160. DOI: 10.1089/jmf.2015.0034.

  86. White, P. A. S., Cercato, L. M., Batista, V. S., Camargo, E. A., De Lucca, W., Oliveira, A. S., Silva, F. T., Goes, T. C., Oliveira, E. R. A., Moraes, V. R. S., Nogueira, P. C. L., De Oliveira, S. A. M., Quintans-Junior, L. J., Lima, B. S., Araújo, A. A. S. & Santos, M. R.V. (2016a). Aqueous extract of Chrysobalanus icaco leaves, in lower doses, prevent fat gain in obese high-fat fed mice. Journal of Ethnopharmacology, 179, 92-100. DOI: 10.1016/j. jep.2015.12.047.

  87. Zekry, S. S. A., Badawy, M.T., Ezzelarab, N. M. & Abdellatif, A. (2021). Phytotherapy for diabetes mellitus; A review of Middle Eastern and North African folk medicinal plants. Journal of Herbmed Pharmacology, 10(1), 1-13. DOI: 10.34172/jhp.2021.01.

  88. Zhang, S., Xu, M., Zhang, W., Liu, C. & Chen, S. (2021). Natural Polyphenols in Metabolic Syndrome: Protective Mechanisms and Clinical Applications. International Journal of Molecular Sciences, 22(6110), 1-34. DOI: 10.3390/ijms22116110.




2020     |     www.medigraphic.com